Treace Medical Concepts Inc (TMCI) Physician Survey Supports 30%+ Sales Growth Outlook - Stifel

June 3, 2021 6:30 AM EDT Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $37.00 price target on Treace Medical Concepts Inc (NASDAQ: TMCI) after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login